Zhejiang Huahai Pharmaceutical Co., Ltd.

¥17.61As of Sun 8 Nov 2026, 12:00 UTC
SSE:600521Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (0.01%)
Div yield 0.57%
ROE 9.19%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM 28.04
TSR TTM (7.54%)
Mkt cap ¥26.24B
ROIC 5.82%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥17
(2.41%)
(5.38%)
Hold 5|9|6|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.32
0.33
0.35
24.36%
28.07%
24.75%
30.90%
Revenue¥B
1.158
1.171
1.148
1.171
(1.57%)
0.77%
1.53%
5.40%
Peers (US$3.934B)
Cap (US$)
PE
4.020B
19.40x
Capital
TTM
5Y
10Y
Leveragex
0.606
0.832
0.805
EBIT/Intx
0.764
0.514
0.485
Own earn%
(73.96)
96.59
85.18
Sh yield%
20.65
33.59
32.04
Owners
Insiders/Inst%
1.71
69.03
Short interest%
1.24
SBC / revenue%
2.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
4